| 12.02.2022 |
11:00:32 |
abbr. pharma. |
OCE |
Oncology Center of Excellence |
| 31.01.2022 |
15:52:36 |
abbr. life.sc. |
MSSG |
Medicine Shortages Steering Group |
| 29.04.2021 |
17:35:27 |
med. |
proficiency studies |
proficiency testing |
| 5.11.2020 |
13:20:00 |
progr. |
dunder |
double underscore (def __init__(self)) |
| 17.06.2019 |
2:54:50 |
abbr. pharm. |
KHIDI |
Korea Health Industry Development Institute (Корейский институт развития медицинской промышленности) |
| 27.05.2019 |
3:06:40 |
abbr. pharm. |
GRASE |
generally recognized as safe and effective |
| 6.03.2019 |
20:49:32 |
abbr. pharm. |
SNIF |
summary notification information format (в контексте получения разрешения на вывод ГМО на рынок в ЕС) |
| 17.01.2019 |
12:40:30 |
abbr. pharm. |
FDARA |
Food and Drug Administration Reauthorization Act |
| 17.01.2019 |
12:40:30 |
abbr. pharm. |
Food and Drug Administration Reauthorization Act |
FDARA |
| 2.07.2018 |
15:06:38 |
abbr. pharm. |
HESDE |
Historical Evidence of Sensitivity to Drug Effects |
| 2.07.2018 |
15:06:38 |
abbr. pharm. |
Historical Evidence of Sensitivity to Drug Effects |
HESDE |
| 19.05.2018 |
10:50:58 |
abbr. pharm. |
ESCOP |
European Scientific Cooperative on Phytotherapy |
| 26.10.2017 |
2:03:17 |
abbr. pharm. |
ECV |
epidemiologic cut-off value (ЗЭО, значение эпидемиологического отсечения) |
| 26.10.2017 |
2:01:50 |
abbr. pharm. |
PTA |
probability of target attainment (ВДН, вероятность достижения нормативов) |
| 26.10.2017 |
2:01:00 |
abbr. pharm. |
PDT |
PK-PD target (ФК-ФД-норматив) |
| 26.10.2017 |
2:01:00 |
abbr. pharm. |
PK-PD target |
PDT (ФК-ФД-норматив) |
| 26.10.2017 |
1:59:36 |
abbr. |
PK-PD index |
Pharmacokinetic-Pharmacodynamic index |
| 11.02.2017 |
12:15:25 |
abbr. pharma. |
ICH |
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use |
| 9.10.2016 |
21:36:41 |
abbr. pharm. |
MAARI |
Medically attended respiratory infection |
| 8.10.2016 |
22:53:20 |
abbr. pharm. |
SRH |
single radial haemolysis |
| 12.09.2016 |
7:52:56 |
abbr. pharm. |
DSUR |
Development Safety Update Report |
| 12.09.2016 |
7:52:56 |
abbr. pharm. |
Development Safety Update Report |
DSUR |
| 17.07.2016 |
18:10:14 |
abbr. pharm. |
RHSC |
Regulatory Harmonization Steering Committee |
| 17.07.2016 |
18:10:14 |
abbr. pharm. |
Regulatory Harmonization Steering Committee |
RHSC |
| 7.07.2016 |
8:18:28 |
toxicol. |
stumptail |
stump-tailed macaque |
| 7.07.2016 |
8:18:28 |
abbr. toxicol. |
stump-tailed macaque |
stumptail |
| 7.07.2016 |
8:11:55 |
abbr. toxicol. |
BSA-CF |
body surface area conversion factor |
| 22.05.2016 |
15:25:37 |
abbr. pharm. |
ICDRA |
International Conference of Drug Regulatory Authorities (Международная конференция уполномоченных органов в сфере обращения лекарственных средств) |
| 22.05.2016 |
15:25:37 |
abbr. pharm. |
International Conference of Drug Regulatory Authorities |
ICDRA (Международная конференция уполномоченных органов в сфере обращения лекарственных средств) |
| 22.05.2016 |
14:59:08 |
abbr. pharm. |
JCBN |
Joint Commission on Biochemical Nomenclature |
| 22.05.2016 |
14:59:08 |
abbr. pharm. |
Joint Commission on Biochemical Nomenclature |
JCBN |
| 22.05.2016 |
13:17:41 |
pharm. |
United States Accepted Names |
USAN |
| 22.05.2016 |
13:17:41 |
abbr. pharm. |
USAN |
United States Accepted Names |
| 24.02.2016 |
21:15:55 |
abbr. pharma. |
PAS |
prior approval supplement (предварительно одобренное досье) |
| 1.02.2016 |
12:04:27 |
abbr. pharm. |
NRG |
Name Review Group |
| 1.02.2016 |
12:04:27 |
abbr. pharm. |
Name Review Group |
NRG |
| 20.01.2016 |
14:02:38 |
abbr. pharma. |
CFSAN |
Center for Food Safety and Applied Nutrition (подразделение FDA) |
| 20.01.2016 |
14:02:38 |
abbr. pharma. |
Center for Food Safety and Applied Nutrition |
CFSAN (подразделение FDA) |
| 15.01.2016 |
19:52:23 |
abbr. pharm. |
SEC |
Single European Code (Единый европейский код) |
| 15.01.2016 |
19:52:23 |
abbr. pharm. |
Single European Code |
SEC (Единый европейский код) |
| 14.01.2016 |
20:15:10 |
abbr. pharm. |
ICCVAM |
Interagency Coordinating Committee on the Validation of Alternative Methods (Межведомственный координационный комитет по валидации альтернативных методов) |
| 14.01.2016 |
20:15:10 |
abbr. pharm. |
Interagency Coordinating Committee on the Validation of Alternative Methods |
ICCVAM (Межведомственный координационный комитет по валидации альтернативных методов) |
| 14.01.2016 |
17:26:14 |
abbr. pharm. |
3R |
Reduction, Refinement, Replacement |
| 14.01.2016 |
17:26:14 |
abbr. pharm. |
Reduction, Refinement, Replacement |
3R |
| 14.01.2016 |
16:44:36 |
abbr. med.appl. |
MAF |
device master file master file for device |
| 14.01.2016 |
16:32:58 |
abbr. pharm. |
ROA |
route of administration (путь введения) |
| 19.12.2015 |
21:58:23 |
abbr. pharm. |
GMMP |
good meeting management practices (надлежащая практика организации встреч) |
| 19.12.2015 |
11:04:39 |
abbr. pharm. |
OBRR |
Office of Blood Research and Review |
| 19.12.2015 |
11:04:39 |
abbr. pharm. |
Office of Blood Research and Review |
OBRR |
| 19.12.2015 |
11:02:43 |
abbr. pharm. |
OVRR |
Office of Vaccines Research and Review |
| 19.12.2015 |
11:02:43 |
abbr. pharm. |
Office of Vaccines Research and Review |
OVRR |
| 19.12.2015 |
10:56:09 |
abbr. pharm. |
RFD |
Request for Designation |
| 13.12.2015 |
10:21:11 |
abbr. pharm. |
SOPP |
Standard Operating Procedures and Policy (стандартные операционные процедуры и правила) |
| 13.12.2015 |
10:21:11 |
abbr. pharm. |
Standard Operating Procedures and Policy |
SOPP (стандартные операционные процедуры и правила) |
| 12.12.2015 |
20:33:41 |
abbr. pharm. |
OCTGT |
Office of Cellular, Tissue and Gene Therapies |
| 12.12.2015 |
20:33:41 |
abbr. pharm. |
Office of Cellular, Tissue and Gene Therapies |
OCTGT |
| 12.12.2015 |
18:49:54 |
abbr. pharm. |
BRC |
Biosimilar Review Committee |
| 12.12.2015 |
18:49:54 |
abbr. pharm. |
Biosimilar Review Committee |
BRC |
| 12.12.2015 |
17:11:13 |
abbr. pharm. |
BsUFA |
Biosimilar User Fee Act |
| 12.12.2015 |
17:11:13 |
abbr. pharm. |
Biosimilar User Fee Act |
BsUFA |
| 30.11.2015 |
8:05:41 |
abbr. pharm. |
MRFG |
Mutual recognition facilitation group |
| 14.11.2015 |
22:59:41 |
abbr. immunol. |
SRD |
single radial diffusion |
| 10.09.2015 |
6:46:39 |
abbr. toxicol. |
MFD |
Maximum Feasible Dose (максимальная достижимая доза (ограничения, как правило, обусловлены физико-химическими свойствами испытуемого материала)) |
| 10.09.2015 |
6:46:39 |
abbr. toxicol. |
Maximum Feasible Dose |
MFD (максимальная достижимая доза (ограничения, как правило, обусловлены физико-химическими свойствами испытуемого материала)) |
| 8.09.2015 |
17:23:53 |
abbr. clin.trial. |
LOCF |
Last Observation Carried Forward (использование последнего документированного значения) |
| 8.09.2015 |
17:23:53 |
abbr. clin.trial. |
Last Observation Carried Forward |
LOCF (использование последнего документированного значения) |
| 8.09.2015 |
17:23:16 |
abbr. clin.trial. |
BOCF |
Baseline Observation Carried Forward (использование исходного документированного значения) |
| 8.09.2015 |
17:23:16 |
abbr. clin.trial. |
Baseline Observation Carried Forward |
BOCF (использование исходного документированного значения) |
| 2.09.2015 |
9:58:31 |
abbr. clin.trial. |
MAR |
missing at random |
| 2.09.2015 |
9:57:41 |
abbr. clin.trial. |
MCAR |
missing completely at random (всецело случайно недостающее (наблюдение)) |
| 2.09.2015 |
9:57:00 |
abbr. clin.trial. |
MNAR |
missing not at random |
| 29.08.2015 |
14:38:42 |
abbr. med. |
Importing Tissue Establishment |
ITE |
| 7.08.2015 |
6:47:16 |
abbr. toxicol. |
RTG |
relative total growth (ОКР, относительный общий рост) |
| 2.08.2015 |
7:16:29 |
abbr. toxicol. |
MLA |
mouse lymphoma assay (mouse lymphoma L5178Y cell Tk (thymidine kinase) gene mutation assay) |
| 31.07.2015 |
14:55:55 |
abbr. toxicol. |
IWGT |
International Workshop on Genotoxicity Testing (Международная группа по испытаниям на генотоксичность (МГИГ)) |
| 31.07.2015 |
14:55:55 |
abbr. toxicol. |
International Workshop on Genotoxicity Testing |
IWGT (Международная группа по испытаниям на генотоксичность (МГИГ)) |
| 8.06.2015 |
19:35:37 |
abbr. pharm. |
VEG |
Vaccine Expert Group (экспертная группа по вакцинам (ЭГВ)) |
| 8.06.2015 |
19:35:37 |
abbr. pharm. |
Vaccine Expert Group |
VEG (экспертная группа по вакцинам (ЭГВ)) |
| 17.05.2015 |
12:12:25 |
abbr. med. |
SEG |
Scientific Expert Group |
| 17.05.2015 |
12:12:25 |
abbr. med. |
Scientific Expert Group |
SEG |
| 17.05.2015 |
11:57:25 |
abbr. med. |
CICAD |
Concise International Chemical Assessment Documents |
| 17.05.2015 |
11:57:25 |
abbr. med. |
Concise International Chemical Assessment Documents |
CICAD |
| 20.04.2015 |
8:06:34 |
abbr. med. |
NNAS |
non-nutritional artificial sweetener (непищевой искусственный подсластитель) |
| 14.04.2015 |
15:52:32 |
abbr. med. |
PTL |
Product Team Leader (Должность в EMA) |
| 14.04.2015 |
15:52:32 |
abbr. med. |
Product Team Leader |
PTL (Должность в EMA) |
| 6.04.2015 |
18:46:12 |
abbr. pharm. |
CTAG |
Clinical Trials Coordination and Advisory Group |
| 6.04.2015 |
18:46:12 |
abbr. pharm. |
Clinical Trials Coordination and Advisory Group |
CTAG |
| 31.03.2015 |
18:46:38 |
abbr. pharm. |
ICTRP |
International Clinical Trials Registry Platform |
| 31.03.2015 |
18:46:38 |
abbr. pharm. |
International Clinical Trials Registry Platform |
ICTRP |
| 18.02.2015 |
21:21:40 |
abbr. immunol. |
CARPA |
complement activation-related pseudoallergy (обусловленная активацией комплемента псевдоаллергия) |
| 15.02.2015 |
11:00:30 |
abbr. clin.trial. |
PROM |
patient-reported outcome measure (показатель исходов, сообщаемых пациентами (ПИСП)) |
| 25.01.2015 |
11:57:13 |
abbr. pharm. |
Co-ordination group for Mutual recognition and Decentralised procedures |
CMDh (Координационная группа по процедуре взаимного признания и децентрализованной процедуре для лекарственных препаратов для медицинского применения) |
| 7.01.2015 |
14:54:13 |
abbr. pharma. |
TDDS |
transdermal drug delivery system |
| 18.11.2014 |
12:22:44 |
abbr. pharma. |
HCT/P |
human cells, tissues, and cellular and tissue-based products (21 CFR 1271) |
| 8.11.2014 |
11:34:00 |
abbr. pharma. |
Less-Than-Lifetime |
LTL (меньшая, чем пожизненная (экспозиция, ICH M7)) |
| 28.09.2014 |
11:35:07 |
abbr. pharma. |
IIRMI |
innate immune response modulating impurity |
| 16.09.2014 |
11:37:14 |
abbr. pharma. |
Normal Operating Range |
NOR |
| 1.09.2014 |
14:31:16 |
abbr. pharma. |
SSFFC |
substandard/spurious/falsely-labelled/falsified/counterfeit (некачественные/поддельные/ложномаркированные/фальсифицированные/контрафактные (лекарственные препараты)) |
| 18.07.2014 |
13:05:31 |
abbr. |
sCTMP |
somatic cell therapy medicinal product (лекарствненый препарат для терапии соматическими клетками) |
| 6.09.2013 |
11:11:35 |
abbr. clin.trial. |
NIMP |
non- investigational medicinal product |
